Related Experiment Videos
[Dilated cardiomyopathies in children]
A M Rossignol1, D Plantaz, A Azoulay
1Service de médecine infantile A, CHU de Grenoble, France.
Insights
Dilated cardiomyopathies in infants significantly impact prognosis, often requiring cardiac transplantation. Echocardiography is crucial for monitoring disease progression and detecting complications like cardiac thrombosis.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Medicine
- Neonatology
Context:
- Dilated cardiomyopathies (DCM) predominantly affect infants, posing a severe threat to vital and functional prognosis.
- DCM can be primary or secondary to conditions like congenital heart defects, toxic drug exposure, or cystic fibrosis.
- Current medical treatments offer limited long-term efficacy, with progressive worsening necessitating consideration of cardiac transplantation for primary or chronic secondary DCM.
Purpose:
- To highlight the critical nature of pediatric dilated cardiomyopathies.
- To outline the etiological factors and progression of DCM in infants.
- To emphasize the role of echocardiography in managing DCM.
Summary:
- Dilated cardiomyopathies (DCM) are a serious concern in infants, impacting their long-term health and survival.
- Etiologies range from primary conditions to secondary causes including congenital malformations, drug toxicity, and cystic fibrosis.
- While medical management is often transiently effective, advanced stages may require cardiac transplantation, with echocardiography serving as a key monitoring tool for disease evolution and complications such as cardiac thrombosis.
Impact:
- Informs clinical practice regarding the management of infant DCM.
- Underscores the importance of early diagnosis and monitoring through echocardiography.
- Provides insight into the prognosis and treatment options, including transplantation, for severe pediatric DCM.
Abstract:
Dilated cardiomyopathies occur mostly in infants and affect their vital and functional prognosis. They may be primary or secondary to various pathologies such as congenital cardiac malformation, toxic myocardial drugs or mucoviscidosis. Medical treatment may only be transiently effective and brutal or progressive aggravation may lead to cardiac transplantation being considered in those cardiomyopathies which are primary (without metabolic causes) or chronic secondary. Echocardiographic survey is the most efficient way to follow the evolution and to detect complications (cardiac thrombosis).